Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 299 Show results per page	View Search Criteria \| Help With Results


1.		Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-Small-Cell Lung Cancer (NSCLC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Other				97-02-12 NCT00686322


2.		A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Treatment				Active				18 and over				Pharmaceutical / Industry				BO21015 2008-000662-23, NCT00700180


3.		Paclitaxel Plus Carboplatin With Endostar in Patients of Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 to 75				Pharmaceutical / Industry				XYL014 NCT00708812

Last Modified: 10/7/2008 First Published: 12/1/1998


4.		Phase II/III Randomized Study of Bleomycin, Cisplatin, and Etoposide (BEP) Versus Bleomycin, Cisplatin, Etoposide, and Paclitaxel (T-BEP) in Men With Intermediate Prognosis Germ Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				16 to 50				Other				EORTC-30983 NCT00003643

Last Modified: 5/22/2007 First Published: 12/23/2003


5.		Phase II/III Randomized Pilot Study of the Timing of Surgery and Chemotherapy in Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				Adult				Other				RCOG-MRC-CHORUS EU-20350, ISRCTN74802813, NCT00075712


6.		Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Other				HFHS 05-03 NCT00448240


7.		Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				OXC4T4-302 NCT00507429


8.		Efficacy Study of Endoscopic Ultrasonography (EUS)-Guided Ethanol Lavage With Paclitaxel Injection for Cystic Tumors of the Pancreas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				20 to 85				Other				AMC0183 NCT00689715


9.		Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				40 to 75				Other				Hamamatsu 18-66 NCT00752115

Last Modified: 6/25/2007 First Published: 3/1/2000


10.		Phase III Randomized Study of First-Line Trastuzumab (Herceptin) Alone Followed By Combination Trastuzumab and Paclitaxel Versus First-Line Combination Trastuzumab and Paclitaxel in Women With HER2-Overexpressing Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 70				Other				SWS-SAKK-22/99 EU-99028, NCT00004935

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute